Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Bonneau

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Bulletin Du Cancer|October 1, 2019
[Impact of nutrition on breast cancer mortality and risk of recurrence, a review of the evidence]Louise Maumy, Guillaume Harrissart, Pauline Dewaele, et al.
Frontiers in Genetics|April 8, 2020
Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian CancerYann Kieffer, Claire Bonneau, Tatiana Popova, et al.
Journal of Translational Medicine|October 5, 2018
Surgical peritoneal stress creates a pro-metastatic niche promoting resistance to apoptosis via IL-8Jennifer Pasquier, Fabien Vidal, Jessica Hoarau-Véchot, et al.
Expert Review of Anticancer Therapy|April 11, 2018
The role of neoadjuvant chemotherapy in ovarian cancerAntoine Elies, Sophie Rivière, Nicolas Pouget, et al.
La Revue Du Praticien|August 6, 2014
[Life after uterine cancer]Martin Koskas, Jean-Michel Rodier, Jean-Jacques Bretel, et al.
Gynecologic Oncology|December 3, 2014
Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinomaClaire Bonneau, Roman Rouzier, Caroline Geyl, et al.
Clinical Breast Cancer|November 10, 2021
Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast CancerLouise Benoit, Carine Cambra, Roman Rouzier, et al.
Anticancer Research|April 13, 2016
Dynamic Analysis of CA125 Decline During Neoadjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer as a Predictor for Platinum SensitivityAurélie Pelissier, Claire Bonneau, Elisabeth Chéreau, et al.
Bulletin Du Cancer|September 26, 2020
[Physical activity after breast cancer diagnosis and survival: A systematic review]Louise Maumy, Eleonora Salakos, Grégoire Rocher, et al.
Gynecologic Oncology|September 17, 2014
CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapyAurélie Pelissier, Claire Bonneau, Elisabeth Chéreau, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Bulletin Du Cancer|October 1, 2019
[Impact of nutrition on breast cancer mortality and risk of recurrence, a review of the evidence]Louise Maumy, Guillaume Harrissart, Pauline Dewaele, et al.
Frontiers in Genetics|April 8, 2020
Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian CancerYann Kieffer, Claire Bonneau, Tatiana Popova, et al.
Journal of Translational Medicine|October 5, 2018
Surgical peritoneal stress creates a pro-metastatic niche promoting resistance to apoptosis via IL-8Jennifer Pasquier, Fabien Vidal, Jessica Hoarau-Véchot, et al.
Expert Review of Anticancer Therapy|April 11, 2018
The role of neoadjuvant chemotherapy in ovarian cancerAntoine Elies, Sophie Rivière, Nicolas Pouget, et al.
La Revue Du Praticien|August 6, 2014
[Life after uterine cancer]Martin Koskas, Jean-Michel Rodier, Jean-Jacques Bretel, et al.
Gynecologic Oncology|December 3, 2014
Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinomaClaire Bonneau, Roman Rouzier, Caroline Geyl, et al.
Clinical Breast Cancer|November 10, 2021
Quality of Life in an e-Cohort of Women Treated by Endocrine Therapy for Early Breast CancerLouise Benoit, Carine Cambra, Roman Rouzier, et al.
Anticancer Research|April 13, 2016
Dynamic Analysis of CA125 Decline During Neoadjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer as a Predictor for Platinum SensitivityAurélie Pelissier, Claire Bonneau, Elisabeth Chéreau, et al.
Bulletin Du Cancer|September 26, 2020
[Physical activity after breast cancer diagnosis and survival: A systematic review]Louise Maumy, Eleonora Salakos, Grégoire Rocher, et al.
Gynecologic Oncology|September 17, 2014
CA125 kinetic parameters predict optimal cytoreduction in patients with advanced epithelial ovarian cancer treated with neoadjuvant chemotherapyAurélie Pelissier, Claire Bonneau, Elisabeth Chéreau, et al.
Pageof 7